Please Wait.....
Report
Artificial Internal Organs Market By Type (Artificial Heart, Artificial Kidney, Artificial Lungs, Others) , By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 280 Pages I Allied Market Research
The artificial internal organs market was valued at $27.4 billion in 2023, and is projected to reach $56.8 billion by 2033, growing at a CAGR of 7.5% from 2024 to 2033.
Artificial internal organs are bioengineered tissues that replace and mimic the functions of naturally occurring organs in individuals whose organs are damaged, dysfunctional, or impaired. They serve as an ideal solution to organ donor shortages, and can also be used as medical training tools. The development of bioartificial organ manufacturing technologies to produce human organs based on bionic principles expected to act as a significant milestone in the artificial internal organs market.
The growth of the global artificial internal organs market is majorly driven by alarming increase in cases of organ failure, despite advancements in pharmacological, interventional, and surgical therapies. Serious organ dysfunction is not only caused due injuries or diseases but also due to nonlife-threatening disabilities such as loss of eyesight or hearing ability, which decreases the quality of life, thereby augmenting the demand for artificial internal organs. Moreover, shortage of donor organs for transplantation acts as a key driving force of the global market. According to the March 2024 statistics of the Organ Procurement and Transplantation Network-operated under contract with the U.S. Department of Health and Human Services by the United Network for Organ Sharing (UNOS)-approximately 103,223 number of men, women, and children are on the national transplant waiting list. As per the same source, 17 individuals die each day waiting for an organ transplant. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fac that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for artificial organ solutions. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. Thus, all these factors substantially contribute to increase in number of organ transplants carried out. The statistics derived from Organ Procurement and Transplantation Network suggest that more than 46,000 organ transplants were performed in 2023. In addition, rise in awareness and acceptance of artificial organ transplants is driving the growth of the market. However, high cost associated with artificial organ transplants, risk of immune rejection, and ethical conflicts act as the key deterrent factors of the global market. On the contrary, technological advancements in artificial internal organs are expected to offer remunerative opportunities for the expansion of the market during the forecast period. For instance, manufacturers are focusing on enhancing the functionality, monitoring capabilities, and overall effectiveness of artificial organs; thus, they are integrating bioelectronics and digital health technologies into artificial organs, which is expected to revolutionize the organ transplant industry in the coming years.
The global artificial internal organs market is segmented into type, end user, and region. By type, the market is categorized into artificial heart, artificial kidney, artificial lungs, and others. On the basis of end user, it is classified into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the artificial hearts segment is projected to register notable growth rate by 2033.
On the basis of end user, the hospital segment dominated the market in 2023.
Region wise, North America was the major revenue generator in 2023 and is anticipated to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global artificial internal organs market include SynCardia Systems LLC, Abbott Laboratories, Cochlear Limited, Boston Scientific Corporation, Johnson & Johnson, Edwards Lifesciences Corporation, Zimmer Biomet Holding Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain maximum share and sustain the intense competition.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
Key Market Segments
By Type
- Artificial Heart
- Artificial Kidney
- Artificial Lungs
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- SynCardia Systems LLC
- Abbott Laboratories
- Cochlear Limited
- Boston Scientific Corporation
- Johnson & Johnson
- Edwards Lifesciences Corporation
- Zimmer Biomet Holding Inc.
- Berlin Heart GmbH
- Jarvik Heart, Inc.
- Medtronic Plc.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Immunofluorescence
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Chemiluminescence
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Enzyme Linked Fluorescent System
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Others
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Infectious Diseases
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Endocrinology
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Drug Monitoring
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Chronic Diseases
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Allergy Testing
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Others
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
CHAPTER 6: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Diagnostic Laboratories
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Pharmaceutical And Biotechnology Companies
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Others
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Automatic Immunoassay Analyzer Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Automatic Immunoassay Analyzer Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Automatic Immunoassay Analyzer Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Automatic Immunoassay Analyzer Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Automatic Immunoassay Analyzer Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Automatic Immunoassay Analyzer Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Automatic Immunoassay Analyzer Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Automatic Immunoassay Analyzer Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Automatic Immunoassay Analyzer Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Automatic Immunoassay Analyzer Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Automatic Immunoassay Analyzer Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Automatic Immunoassay Analyzer Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Automatic Immunoassay Analyzer Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Automatic Immunoassay Analyzer Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Automatic Immunoassay Analyzer Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Automatic Immunoassay Analyzer Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Automatic Immunoassay Analyzer Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Automatic Immunoassay Analyzer Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Automatic Immunoassay Analyzer Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Meril Life Sciences Pvt. Ltd.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. BioMerieux
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Arlington Scientific
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. F. Hoffmann-La Roche Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Carolina Liquid Chemistries
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Becton Dickinson And Company,
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Bio-Rad Laboratories, Inc
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. PerkinElmer Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. AESKU.GROUP GmbH
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ARTIFICIAL INTERNAL ORGANS MARKET FOR ARTIFICIAL HEART, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ARTIFICIAL INTERNAL ORGANS MARKET FOR ARTIFICIAL KIDNEY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. ARTIFICIAL INTERNAL ORGANS MARKET FOR ARTIFICIAL LUNGS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. ARTIFICIAL INTERNAL ORGANS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. GLOBAL ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 7. ARTIFICIAL INTERNAL ORGANS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ARTIFICIAL INTERNAL ORGANS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. ARTIFICIAL INTERNAL ORGANS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. ARTIFICIAL INTERNAL ORGANS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA ARTIFICIAL INTERNAL ORGANS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 14. U.S. ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 15. U.S. ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 16. CANADA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 17. CANADA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. MEXICO ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 19. MEXICO ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE ARTIFICIAL INTERNAL ORGANS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 21. EUROPE ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 22. EUROPE ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. FRANCE ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. GERMANY ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 26. GERMANY ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. ITALY ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 28. ITALY ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. SPAIN ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. UK ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 32. UK ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. REST OF EUROPE ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 34. REST OF EUROPE ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC ARTIFICIAL INTERNAL ORGANS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 36. ASIA-PACIFIC ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 37. ASIA-PACIFIC ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 38. CHINA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 39. CHINA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. JAPAN ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 41. JAPAN ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. INDIA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 43. INDIA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. SOUTH KOREA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 45. SOUTH KOREA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. AUSTRALIA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 47. AUSTRALIA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. REST OF ASIA-PACIFIC ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 49. REST OF ASIA-PACIFIC ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA ARTIFICIAL INTERNAL ORGANS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 51. LAMEA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 52. LAMEA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. BRAZIL ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. BRAZIL ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. SOUTH AFRICA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. SAUDI ARABIA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 58. SAUDI ARABIA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. REST OF LAMEA ARTIFICIAL INTERNAL ORGANS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 60. REST OF LAMEA ARTIFICIAL INTERNAL ORGANS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. SYNCARDIA SYSTEMS LLC: KEY EXECUTIVES
TABLE 62. SYNCARDIA SYSTEMS LLC: COMPANY SNAPSHOT
TABLE 63. SYNCARDIA SYSTEMS LLC: OPERATING SEGMENTS
TABLE 64. SYNCARDIA SYSTEMS LLC: PRODUCT PORTFOLIO
TABLE 65. SYNCARDIA SYSTEMS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 66. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 67. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 68. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 69. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 70. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 71. COCHLEAR LIMITED: KEY EXECUTIVES
TABLE 72. COCHLEAR LIMITED: COMPANY SNAPSHOT
TABLE 73. COCHLEAR LIMITED: OPERATING SEGMENTS
TABLE 74. COCHLEAR LIMITED: PRODUCT PORTFOLIO
TABLE 75. COCHLEAR LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 76. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 77. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 78. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 79. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 80. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 81. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 82. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 83. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 84. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 85. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 86. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 87. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 88. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 89. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 90. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 92. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 93. ZIMMER BIOMET HOLDING INC.: OPERATING SEGMENTS
TABLE 94. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 95. ZIMMER BIOMET HOLDING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. BERLIN HEART GMBH: KEY EXECUTIVES
TABLE 97. BERLIN HEART GMBH: COMPANY SNAPSHOT
TABLE 98. BERLIN HEART GMBH: OPERATING SEGMENTS
TABLE 99. BERLIN HEART GMBH: PRODUCT PORTFOLIO
TABLE 100. BERLIN HEART GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. JARVIK HEART, INC.: KEY EXECUTIVES
TABLE 102. JARVIK HEART, INC.: COMPANY SNAPSHOT
TABLE 103. JARVIK HEART, INC.: OPERATING SEGMENTS
TABLE 104. JARVIK HEART, INC.: PRODUCT PORTFOLIO
TABLE 105. JARVIK HEART, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. MEDTRONIC PLC.: KEY EXECUTIVES
TABLE 107. MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 108. MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 109. MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 110. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ARTIFICIAL INTERNAL ORGANS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ARTIFICIAL INTERNAL ORGANS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ARTIFICIAL INTERNAL ORGANS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALARTIFICIAL INTERNAL ORGANS MARKET
FIGURE 10. GLOBAL ARTIFICIAL INTERNAL ORGANS MARKET SEGMENTATION, BY TYPE
FIGURE 11. ARTIFICIAL INTERNAL ORGANS MARKET FOR ARTIFICIAL HEART, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ARTIFICIAL INTERNAL ORGANS MARKET FOR ARTIFICIAL KIDNEY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ARTIFICIAL INTERNAL ORGANS MARKET FOR ARTIFICIAL LUNGS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. ARTIFICIAL INTERNAL ORGANS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. GLOBAL ARTIFICIAL INTERNAL ORGANS MARKET SEGMENTATION, BY END USER
FIGURE 16. ARTIFICIAL INTERNAL ORGANS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. ARTIFICIAL INTERNAL ORGANS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. ARTIFICIAL INTERNAL ORGANS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 23. COMPETITIVE DASHBOARD
FIGURE 24. COMPETITIVE HEATMAP: ARTIFICIAL INTERNAL ORGANS MARKET
FIGURE 25. TOP PLAYER POSITIONING, 2023
FIGURE 26. SYNCARDIA SYSTEMS LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 27. SYNCARDIA SYSTEMS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 28. SYNCARDIA SYSTEMS LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 29. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. COCHLEAR LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. COCHLEAR LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. COCHLEAR LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. ZIMMER BIOMET HOLDING INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. BERLIN HEART GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. BERLIN HEART GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. BERLIN HEART GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. JARVIK HEART, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. JARVIK HEART, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. JARVIK HEART, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. MEDTRONIC PLC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security